IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway
Open Access
- 10 August 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 485, 27-37
- https://doi.org/10.1016/j.canlet.2020.04.025
Abstract
No abstract availableFunding Information
- AMP
- National Science Council (MOST 106-2314-B-037-005-MY2, MOST108-2320-B-075B-005, MOST107-2314-B-037-097-MY2)
- Kaohsiung Medical University Hospital (KMUH107-7R91, KMUH107-7R36)
- NCTU-KMU (NCTUKMU108-DR-01)
This publication has 51 references indexed in Scilit:
- AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net PhosphorylationCell Metabolism, 2013
- Suppression of Mitochondrial Complex I Influences Cell Metastatic PropertiesPLOS ONE, 2013
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In VivoCell Metabolism, 2013
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stressNature, 2012
- Chondrodysplasia and Abnormal Joint Development Associated with Mutations in IMPAD1, Encoding the Golgi-Resident Nucleotide Phosphatase, gPAPPAmerican Journal of Human Genetics, 2011
- Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancerOncogene, 2011
- Adenosine A1 receptor, a target and regulator of estrogen receptorα action, mediates the proliferative effects of estradiol in breast cancerOncogene, 2009
- The LKB1–AMPK pathway: metabolism and growth control in tumour suppressionNature Reviews Cancer, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfationProceedings of the National Academy of Sciences of the United States of America, 2008